These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2127571)

  • 21. Hyperglycemic properties of serotonin receptor antagonists.
    Wozniak KM; Linnoila M
    Life Sci; 1991; 49(2):101-9. PubMed ID: 1905770
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of various serotonin receptor subtype-selective antagonists alone and on m-chlorophenylpiperazine-induced neuroendocrine changes in rats.
    Aulakh CS; Hill JL; Murphy DL
    J Pharmacol Exp Ther; 1992 Nov; 263(2):588-95. PubMed ID: 1432690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fenfluramine-induced pulmonary vasoconstriction: role of serotonin receptors and potassium channels.
    Belohlávková S; Simák J; Kokesová A; Hnilicková O; Hampl V
    J Appl Physiol (1985); 2001 Aug; 91(2):755-61. PubMed ID: 11457791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of naloxone and naltrexone on the development of satiation measured in the runway: comparisons with d-amphetamine and d-fenfluramine.
    Kirkham TC; Blundell JE
    Pharmacol Biochem Behav; 1986 Jul; 25(1):123-8. PubMed ID: 3749218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An investigation into the effects of 5-HT agonists and receptor antagonists on ethanol self-administration in the rat.
    Wilson AW; Neill JC; Costall B
    Alcohol; 1998 Oct; 16(3):249-70. PubMed ID: 9744857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mediation of ACTH and prolactin responses to 5-HTP by 5-HT2 receptors.
    Gartside SE; Cowen PJ
    Eur J Pharmacol; 1990 Apr; 179(1-2):103-9. PubMed ID: 2163847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parabrachial infusion of D-fenfluramine reduces food intake. Blockade by the 5-HT(1B) antagonist SB-216641.
    Simansky KJ; Nicklous DM
    Pharmacol Biochem Behav; 2002 Apr; 71(4):681-90. PubMed ID: 11888559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The 5-HT1B receptor mediates the effect of d-fenfluramine on eating caused by intra-hypothalamic injection of neuropeptide Y.
    Grignaschi G; Sironi F; Samanin R
    Eur J Pharmacol; 1995 Feb; 274(1-3):221-4. PubMed ID: 7768274
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does metergoline selectively attenuate 5-HT mediated prolactin release?
    Ellis PM; Gartside SE; Ware CJ; Campling GM; Cowen PJ
    Psychopharmacology (Berl); 1991; 105(1):129-31. PubMed ID: 1745704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of 5-hydroxytryptamine and d-fenfluramine on sham feeding and sham drinking in the gastric-fistulated rat.
    Neill JC; Cooper SJ
    Physiol Behav; 1989 Dec; 46(6):949-53. PubMed ID: 2634259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of the 5-HT2 receptor in the 5-HT receptor-mediated stimulation of prolactin release.
    Albinsson A; Palazidou E; Stephenson J; Andersson G
    Eur J Pharmacol; 1994 Jan; 251(2-3):157-61. PubMed ID: 8149973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Central 5-hydroxytryptamine2 receptors are involved in the adrenal catecholamine-releasing and hyperglycemic effects of the 5-hydroxytryptamine indirect agonist d-fenfluramine in the conscious rat.
    Chaouloff F; Gunn SH; Young JB
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1008-16. PubMed ID: 1545373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The 5-HT1A and 5-HT2A/2C receptor antagonists WAY-100635 and ritanserin do not attenuate D-fenfluramine-induced fos expression in the brain.
    Javed A; Van de Kar LD; Gray TS
    Brain Res; 1998 Apr; 791(1-2):67-74. PubMed ID: 9593827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sleep suppressant action of fenfluramine in rats. I. Relation to postsynaptic serotonergic stimulation.
    Fornal C; Radulovacki M
    J Pharmacol Exp Ther; 1983 Jun; 225(3):667-74. PubMed ID: 6683311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for 5-HT2 receptor mediation in quipazine anorexia.
    Shukla R; MacKenzie-Taylor D; Rech RH
    Psychopharmacology (Berl); 1990; 100(1):115-8. PubMed ID: 2296618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of d-fenfluramine and metergoline on responding for conditioned reward and the response potentiating effect of nucleus accumbens d-amphetamine.
    Fletcher PJ
    Psychopharmacology (Berl); 1995 Mar; 118(2):155-63. PubMed ID: 7617802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of xylamidine on peripheral 5-hydroxytryptamine-induced anorexia.
    Edwards S; Stevens RG
    Pharmacol Biochem Behav; 1989 Dec; 34(4):717-20. PubMed ID: 2623027
    [TBL] [Abstract][Full Text] [Related]  

  • 38. From fenfluramine racemate to d-fenfluramine. Specificity and potency of the effects on the serotoninergic system and food intake.
    Garattini S; Mennini T; Samanin R
    Ann N Y Acad Sci; 1987; 499():156-66. PubMed ID: 2440376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ritanserin attenuates anorectic, endocrine and thermic responses to d-fenfluramine in human volunteers.
    Goodall EM; Cowen PJ; Franklin M; Silverstone T
    Psychopharmacology (Berl); 1993; 112(4):461-6. PubMed ID: 7871058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential actions of serotonin antagonists on two behavioral models of serotonin receptor activation in the rat.
    Lucki I; Nobler MS; Frazer A
    J Pharmacol Exp Ther; 1984 Jan; 228(1):133-9. PubMed ID: 6694097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.